Xie Y - Search Results

1

Trends of Hypercholesterolemia Change in Shenzhen, China During 1997-2018.

Peng K, Cai W, Liu X, Liu Y, Shi Y, Gong J, Lei L, Peng J, Xie Y, Zhao H, Si L, Ouyang M. Peng K, et al. Among authors: xie y. Front Public Health. 2022 May 2;10:887065. doi: 10.3389/fpubh.2022.887065. eCollection 2022. Front Public Health. 2022. PMID: 35586010 Free PMC article.

2

Impacts of birthplace and complications on the association between cold exposure and acute myocardial infarction morbidity in the Migrant City: A time-series study in Shenzhen, China.

Peng K, Yan W, Cao Y, Cai W, Liu F, Lin K, Xie Y, Li Y, Lei L, Bao J. Peng K, et al. Among authors: xie y. Sci Total Environ. 2022 Dec 15;852:158528. doi: 10.1016/j.scitotenv.2022.158528. Epub 2022 Sep 3. Sci Total Environ. 2022. PMID: 36063933 No abstract available.

3

Association Between Solid Fuel Use and the Risk of Hypertension in China.

Fu Z, Wang S, Xie H, Xie Y, Wen X, Zheng J, Shi Y, Li Y. Fu Z, et al. Among authors: xie h, xie y. J Occup Environ Med. 2023 Sep 1;65(9):725-730. doi: 10.1097/JOM.0000000000002887. Epub 2023 May 17. J Occup Environ Med. 2023. PMID: 37193641

4

Trends of mean systolic and diastolic blood pressure among adults in Shenzhen, China, 1997-2018: findings from three rounds of the population-based survey.

Peng K, Cai W, Liu X, Liu Y, Ouyang M, Gong J, Wang Z, Wang Y, Hao J, Wang W, Zhao H, Lin K, Han G, Shi Y, Xie Y, Xie Y, Lei L, Si L. Peng K, et al. Among authors: xie y. BMJ Open. 2024 Feb 10;14(2):e074575. doi: 10.1136/bmjopen-2023-074575. BMJ Open. 2024. PMID: 38341201 Free PMC article.

5

Targeted Mitochondrial Drugs for Treatment of Ischemia-Reperfusion Injury.

Peng JF, Salami OM, Habimana O, Xie YX, Yao H, Yi GH. Peng JF, et al. Curr Drug Targets. 2022;23(16):1526-1536. doi: 10.2174/1389450123666220913121422. Curr Drug Targets. 2022. PMID: 36100990 Review.

6

Mitochondria-Associated Organelle Crosstalk in Myocardial Ischemia/Reperfusion Injury.

Yao H, Xie Y, Li C, Liu W, Yi G. Yao H, et al. Among authors: xie y. J Cardiovasc Transl Res. 2024 Oct;17(5):1106-1118. doi: 10.1007/s12265-024-10523-9. Epub 2024 May 28. J Cardiovasc Transl Res. 2024. PMID: 38807004 Review.

7

Insight into modulators of sphingosine-1-phosphate receptor and implications for cardiovascular therapeutics.

Xie YX, Yao H, Peng JF, Ni D, Liu WT, Li CQ, Yi GH. Xie YX, et al. J Drug Target. 2024 Dec;32(3):300-310. doi: 10.1080/1061186X.2024.2309577. Epub 2024 Feb 6. J Drug Target. 2024. PMID: 38269855 Review.

8

Therapeutic implication of targeting mitochondrial drugs designed for efferocytosis dysfunction.

Liu WT, Li CQ, Fu AN, Yang HT, Xie YX, Yao H, Yi GH. Liu WT, et al. J Drug Target. 2024 Dec;32(10):1169-1185. doi: 10.1080/1061186X.2024.2386620. Epub 2024 Aug 12. J Drug Target. 2024. PMID: 39099434 Review.

9

Concomitant Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma and Non-Immunoglobulin M Plasma Cell Neoplasm.

Zhao Y, Petersen P, Stuart S, He J, Ju Y, Carrillo LF, Carlsen ED, Xie Y, Ghezavati A, Siddiqi I, Zhang L, Wang E. Zhao Y, et al. Among authors: xie y. Arch Pathol Lab Med. 2025 Jan 13. doi: 10.5858/arpa.2024-0270-OA. Online ahead of print. Arch Pathol Lab Med. 2025. PMID: 39800880

10

A label-free electrochemical biosensor based on graphene quantum dots-nanoporous gold nanocomposite for highly sensitive detection of glioma cell.

Wang X, Li X, Wang B, Xie Y, Cui X, Jiao J, Jiao J, Zhang Y. Wang X, et al. Among authors: xie y. Anal Chim Acta. 2025 Feb 1;1337:343555. doi: 10.1016/j.aca.2024.343555. Epub 2024 Dec 16. Anal Chim Acta. 2025. PMID: 39800511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,246 results

Search Page

Filters